ADVANCED NON-SMALL CELL LUNG CANCER
Clinical trials for ADVANCED NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for ADVANCED NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo offers hope for Drug-Resistant lung cancer
Disease control Not yet recruitingThis study tests whether adding a new drug (capivasertib) to the standard drug osimertinib can help people with a specific type of advanced lung cancer that has stopped responding to treatment. About 53 adults with certain genetic changes in their tumors will receive the combinat…
Matched conditions: ADVANCED NON-SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Shanxi Province Cancer Hospital • Aim: Disease control
Last updated May 11, 2026 20:51 UTC
-
Blood test may predict lung cancer treatment success
Knowledge-focused Not yet recruitingThis study looks at whether changes in certain immune cells in the blood can help predict how well chemotherapy combined with immunotherapy works for people with advanced non-small cell lung cancer. Researchers will take blood samples before and after the first two treatment cycl…
Matched conditions: ADVANCED NON-SMALL CELL LUNG CANCER
Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Knowledge-focused
Last updated May 11, 2026 20:39 UTC